Pieter Wesseling Selected Research

Pieter Wesseling Research Topics

Disease

89	Neoplasms (Cancer) 01/2022 - 07/2003
60	Glioma (Gliomas) 01/2022 - 11/2004
32	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2006
15	Brain Neoplasms (Brain Tumor) 11/2021 - 07/2003
10	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2002
7	Diffuse Intrinsic Pontine Glioma 01/2018 - 07/2011
5	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 01/2016
5	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2010
4	Oligodendroglioma 01/2020 - 03/2010
4	Hypoxia (Hypoxemia) 05/2017 - 02/2004
4	Melanoma (Melanoma, Malignant) 03/2010 - 09/2003
4	Amyloid Plaque 10/2004 - 07/2002
4	Alzheimer Disease (Alzheimer's Disease) 10/2004 - 07/2002
3	Medulloblastoma 01/2022 - 01/2018
3	Neurilemmoma (Schwannoma) 09/2014 - 04/2007
2	Ependymoma 01/2022 - 11/2003
2	Rhabdoid Tumor (Rhabdoid Tumors) 10/2021 - 09/2014
2	Multiple Sclerosis 10/2020 - 06/2005
2	Necrosis 01/2019 - 06/2012
2	Uveal melanoma 06/2015 - 04/2015
2	Keratitis 06/2005 - 05/2003
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2005 - 10/2002
1	Central Nervous System Neoplasms 01/2022
1	Germinoma 01/2022
1	Residual Neoplasm 12/2021
1	Pleomorphic Adenoma 11/2021
1	Turcot syndrome 01/2021
1	Vomiting 01/2021
1	Nausea 01/2021
1	Meningioma (Meningiomas) 01/2021

Drug/Important Bio-Agent (IBA)

16	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 10/2007
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2005
12	Pharmaceutical PreparationsIBA 12/2021 - 01/2013
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2006
9	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2010
8	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 07/2011
6	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2015
6	dipinacoline glutamateIBA 05/2017 - 07/2011
6	Vincristine (Oncovin)FDA LinkGeneric 03/2016 - 12/2009
6	Procarbazine (Matulane)FDA Link 03/2016 - 12/2009
5	ParaffinIBA 06/2021 - 10/2009
5	Biological ProductsIBA 01/2021 - 10/2009
5	Lomustine (CCNU)FDA Link 03/2016 - 12/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2004
4	tetraethylpyrazine (TEP)IBA 10/2020 - 11/2015
4	LigandsIBA 01/2020 - 08/2010
4	Alkylating AgentsIBA 12/2019 - 10/2007
4	Formaldehyde (Formol)FDA Link 06/2015 - 10/2009
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013 - 09/2004
4	vandetanib (ZD6474)IBA 06/2012 - 09/2004
3	MethyltransferasesIBA 01/2021 - 07/2011
3	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 07/2018
3	GadoliniumIBA 01/2020 - 01/2012
3	Bevacizumab (Avastin)FDA Link 01/2018 - 12/2013
3	Peptides (Polypeptides)IBA 01/2018 - 02/2004
3	cabozantinibIBA 11/2017 - 01/2013
3	Phosphotransferases (Kinase)IBA 11/2017 - 03/2010
3	NADP (NADPH)IBA 01/2016 - 05/2013
3	Protein Tyrosine PhosphatasesIBA 01/2016 - 02/2010
3	Messenger RNA (mRNA)IBA 01/2016 - 06/2014
3	Tyrosine Kinase InhibitorsIBA 12/2013 - 09/2004
3	Contrast MediaIBA 01/2012 - 07/2003
3	Codon (Codons)IBA 12/2010 - 03/2008
3	Amyloid (Amyloid Fibrils)IBA 01/2005 - 10/2002
3	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 10/2004 - 07/2002
2	epidermal growth factor receptor VIIIIBA 01/2021 - 10/2009
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2020 - 01/2018
2	alpha-hydroxyglutarateIBA 10/2020 - 05/2013
2	NucleotidesIBA 12/2019 - 01/2018
2	89Zr-bevacizumabIBA 01/2018 - 01/2016
2	Chemokine ReceptorsIBA 01/2018 - 08/2010
2	Complement System Proteins (Complement)IBA 01/2018 - 09/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2017 - 02/2010
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2016 - 02/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2012 - 01/2010
2	Growth Factor ReceptorsIBA 02/2010 - 08/2007
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 05/2008 - 07/2003
2	Gadolinium DTPA (Magnevist)FDA Link 05/2008 - 07/2003
2	ferric oxide (iron oxide)IBA 05/2008 - 07/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2007 - 02/2004
2	Monoclonal AntibodiesIBA 07/2007 - 02/2004
2	Protein Isoforms (Isoforms)IBA 11/2006 - 09/2003
2	Voriconazole (Vfend)FDA LinkGeneric 06/2005 - 05/2003
2	Amyloid beta-PeptidesIBA 10/2004 - 07/2002
1	68Ga-pentixaforIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	Retroelements (Retrotransposon)IBA 10/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	isocitrate dehydrogenase (NADP+)IBA 01/2021

Therapy/Procedure

25	Therapeutics 01/2022 - 07/2003
18	Drug Therapy (Chemotherapy) 01/2022 - 10/2007
17	Radiotherapy 01/2022 - 11/2003
10	Ligation 06/2015 - 10/2005
7	Immunotherapy 01/2020 - 07/2007
4	Aftercare (After-Treatment) 01/2021 - 09/2004
1	Chemoradiotherapy 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Conformal Radiotherapy 01/2021